Refine Results
  1. "Mark Kris"
Formats
  1. Journal Article (337)
  2. Meeting Abstract (225)
  3. Book Section (7)
  4. Conference Paper (2)
Groups
  1. Solid Tumor Oncology Division (571)
  2. Thoracic Malignancies Disease Management Team (571)
  3. Thoracic Oncology Service (571)
  4. Thoracic Oncology (561)
  5. Human Oncology and Pathogenesis Program (184)
  6. Soft Tissue Sarcoma Disease Management Team (149)

More Groups

People
  1. Mark Kris (571)
  2. Vincent Miller (158)
  3. Gregory Riely (151)
  4. Marc Ladanyi (127)
  5. Valerie Rusch (99)
  6. Maureen Zakowski (88)

More People

Years
  1. 2018 (20)
  2. 2017 (20)
  3. 2016 (23)
  4. 2015 (42)
  5. 2014 (34)
  6. 2013 (46)

More Years

Publications
  1. Journal of Clinical Oncology (134)
  2. Journal of Thoracic Oncology (95)
  3. Clinical Cancer Research (51)
  4. Lung Cancer (28)
  5. Cancer (24)
  6. Annals of Oncology (17)

More Publications

Publishers
  1. American Society of Clinical Oncology (140)
  2. Elsevier Inc. (119)
  3. American Association for Cancer Research (80)
  4. Elsevier Ireland Ltd. (29)
  5. Oxford University Press (27)
  6. Nature Publishing Group (25)

More Publishers

Results (571)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular and imaging predictors of response to ado-trastuzumab emtansine in patients with HER2 mutant lung cancers: An exploratory phase 2 trial
    Meeting Abstract

    Li, B.; Offin, M.; Hembrough, T.; Cecchi, F.; Shen, R.; Olah, Z.; Panora, E.; Myers, M.; Brzostowski, E.; Buonocore, D.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • MET exon 14-altered lung cancers: Central nervous system (CNS) metastases and patterns of CNS progression on MET inhibition
    Meeting Abstract

    Offin, M.; Dienstag, J.; Wilkins, O.; Sabari, J.; Ni, A.; Feldman, D.; Van Voorthuysen, M.; Suzawa, K.; Yu, H.; Riely, G.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Clinical and molecular characteristics of EGFR mutant lung cancers with concurrent TP53 and RB1 mutations
    Meeting Abstract

    Offin, M.; Tenet, M.; Shen, R.; Rekhtman, N.; Rizvi, H.; Hellmann, M.; Arcila, M.; Ladanyi, M.; Rudin, C.; Kris, M.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Updated results from a multicenter study (LCMC3)
    Meeting Abstract

    Rusch, V.; Chaft, J.; Johnson, B.; Wistuba, I.; Kris, M.; Lee, J.; Bunn, P. Jr; Kwiatkowski, D.; Reckamp, K.; Finley, D.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Comprehensive peripheral blood immunophenotyping and T-cell clonal analysis during neoadjuvant immunotherapy with atezolizumab in NSCLC
    Meeting Abstract

    Oezkan, F.; He, K.; Owen, D.; Pietrzak, M.; Kitzler, R.; Pearson, R.; Nicholas, A.; Bunn, P. Jr; Kris, M.; Kwiatkowski, D.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Current status and future perspectives on neoadjuvant therapy in lung cancer
    Journal Article

    Blumenthal, G. M.; Bunn, P. A. Jr; Chaft, J. E.; McCoach, C. E.; Perez, E. A.; Scagliotti, G. V.; Carbone, D. P.; Aerts, H. J. W. L.; Aisner, D. L.; Bergh, J.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers
    Journal Article

    Sabari, J. K.; Leonardi, G. C.; Shu, C. A.; Umeton, R.; Montecalvo, J.; Ni, A.; Chen, R.; Dienstag, J.; Mrad, C.; Bergagnini, I.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine for patients with HER2-mutant lung cancers: Results from a phase II basket trial
    Journal Article

    Li, B. T.; Shen, R. L.; Buonocore, D.; Olah, Z. T.; Ni, A.; Ginsberg, M. S.; Ulaner, G. A.; Offin, M.; Feldman, D.; Hembrough, T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Frequency of brain metastases and multikinase inhibitor outcomes in patients with RET–rearranged lung cancers
    Journal Article

    Drilon, A.; Lin, J. J.; Filleron, T.; Ni, A.; Milia, J.; Bergagnini, I.; Hatzoglou, V.; Velcheti, V.; Offin, M.; Li, B.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Randomized, double-blind, phase II study of temozolomide in combination with either veliparib or placebo in patients with relapsed-sensitive or refractory small-cell lung cancer
    Journal Article

    Pietanza, M. C.; Waqar, S. N.; Krug, L. M.; Dowlati, A.; Hann, C. L.; Chiappori, A.; Owonikoko, T. K.; Woo, K. M.; Cardnell, R. J.; Fujimoto, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save